Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.69 extracted from

  • Kumaran, D.; Rawat, R.; Ludivico, M.L.; Ahmed, S.A.; Swaminathan, S.
    Structure and substrate based inhibitor design for clostridium botulinum neurotoxin serotype A (2008), J. Biol. Chem., 283, 18883-18891.
    View publication on PubMed

Application

Application Comment Organism
drug development the enzyme is a target for design of specific inhibitors Clostridium botulinum
additional information the enzyme is used as a biowapon Clostridium botulinum

Crystallization (Commentary)

Crystallization (Comment) Organism
purified recombinant enzyme free or in complex with substrate analogue inhibitor peptides, sitting drop vapor diffusion method at room temperature, 0.002 ml of 20 mg/ml enzyme in 2 mM DTT, 200 mM NaCl, and 20 mM HEPES, pH 7.4, is mixed with 0.002 ml reservoir solution containing 15% w/v PEG 3350, 0.3 M ammonium sulfate and 100 mM Bis-Tris buffer, pH 6.8 , equilibration against 0.8 ml of reservoir solution, plate-like crystals within a week, recombinant Balc424 is co-crystallized individually with the tetrapeptides, sitting drop vapor diffusion method at room temperature using conditions similar to native protein, Balc424 gives good complex crystals with RRGC, RRGM, RRGL and RRGI at stoichiometric ratios of 1:30, 1:30, 1:40 and 1:40, respectively, X-ray diffraction structure determination and analysis at 1.6-1.8 A resolution Clostridium botulinum

Inhibitors

Inhibitors Comment Organism Structure
RRGC an inhibitory substrate analogue tetrapeptide, binding structure, overview Clostridium botulinum
RRGI an inhibitory substrate analogue tetrapeptide, binding structure, overview Clostridium botulinum
RRGL an inhibitory substrate analogue tetrapeptide, binding structure, overview Clostridium botulinum
RRGM an inhibitory substrate analogue tetrapeptide, binding structure, overview Clostridium botulinum

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
additional information Clostridium botulinum the seven antigenically distinct serotypes of Clostridium botulinum neurotoxins cleave specific SNARE complex proteins and block the release of neurotransmitters causing flaccid paralysis and are considered potential bioweapons, botulinum neurotoxin type A is the most potent among the clostridial neurotoxins ?
-
?

Organism

Organism UniProt Comment Textmining
Clostridium botulinum P10845 seven antigenically distinct serotypes of neurotoxins
-

Reaction

Reaction Comment Organism Reaction ID
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevin (also known as neuronal vesicle-associated membrane protein, VAMP), synaptosome-associated protein of 25 kDa (SNAP25) or syntaxin. No detected action on small molecule substrates enzyme-substrate interaction at the active site, Tyr366 and Arg363 are important for catalysis, the S1' site is formed by Phe194, Thr215, Thr220, Asp370, and Arg363, reaction mechanism, overview Clostridium botulinum

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
additional information the seven antigenically distinct serotypes of Clostridium botulinum neurotoxins cleave specific SNARE complex proteins and block the release of neurotransmitters causing flaccid paralysis and are considered potential bioweapons, botulinum neurotoxin type A is the most potent among the clostridial neurotoxins Clostridium botulinum ?
-
?

Synonyms

Synonyms Comment Organism
Balc424
-
Clostridium botulinum
botulinum neurotoxin type A
-
Clostridium botulinum
Clostridium botulinum neurotoxin serotype A
-
Clostridium botulinum